0 items USD 0.00Search
Your search for "delveinsight prostate cancer global api manufacturers marketed phase iii drugs landscape 2015" gave back 961 results.
The molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. Molecular diagnostics is a new...
Catalog:
iGATE
September 2016
Price: USD 1,100.00
Indian pharma retail market is expected to grow in near future as aging and growing population, rising income levels, and emerging medical conditions...
Catalog:
NAVADHI
June 2019
Price: USD 1,000.00
The unprecedented demand of proton therapy for the treatment of cancer has set the stage for the market to move ahead at a rapid pace. It is...
Catalog:
iGATE
July 2017
Price: USD 1,950.00
With much-awaited approval of biosimilar interchangeability by FDA, the dynamics in the much nascent US biosimilars market is about to change with...
Catalog:
Rockville Research
January 2017
Price: USD 1,200.00
The adult vaccines market has been forecasted to increase at a compound annual growth rate (CAGR) of around 6% over the next five years. Adults are...
Catalog:
iGATE
August 2016
Price: USD 1,490.00
India is expected to witness a remarkable rise in healthcare infrastructure in upcoming years. There will there be a dramatic rise in the type and...
Catalog:
NAVADHI
June 2019
Price: USD 1,000.00
Asia proton therapy market is anticipated to almost three-fold during the period 2016 – 2022. The number of proton therapy centers is continuously...
Catalog:
iGATE
May 2017
Price: USD 1,450.00
Indian pharma retail market is expected to grow in near future as aging and growing population, rising income levels, and emerging medical conditions...
Catalog:
NAVADHI
June 2019
Price: USD 1,100.00
India pharmaceutical market was the 11 th largest pharmaceuticals market by value in the world in 2017. It is expected to register second highest...
Catalog:
NAVADHI
April 2019
Price: USD 3,500.00
The Indian pharma industry has always been a leading industrial sector in the country, with a paralleled dominance of both domestic and foreign...
Catalog:
RNCOS
June 2022
Price: USD 900.00
India is on the verge to witness a major transformation not only in terms of its social stature but in economic repute too. With correct measures...
Catalog:
Enincon
November 2016
Price: USD 2,199.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The key business segments of Aurobindo Pharma are APIs, Formulations...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Dr. Reddy’s Laboratories is an India based multinational...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The business segments of Lupin mainly comprise of APIs and...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Ipca Labs was founded by K.B. Mehla and Dr. N.S. Tibrawala in 1949...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
